Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Cell Rep ; 42(8): 112972, 2023 08 29.
Artículo en Inglés | MEDLINE | ID: mdl-37578860

RESUMEN

Bacteriophage T3 encodes a SAMase that, through cleavage of S-adenosyl methionine (SAM), circumvents the SAM-dependent type I restriction-modification (R-M) defense. We show that SAMase also allows T3 to evade the BREX defense. Although SAM depletion weakly affects BREX methylation, it completely inhibits the defensive function of BREX, suggesting that SAM could be a co-factor for BREX-mediated exclusion of phage DNA, similar to its anti-defense role in type I R-M. The anti-BREX activity of T3 SAMase is mediated not just by enzymatic degradation of SAM but also by direct inhibition of MetK, the host SAM synthase. We present a 2.8 Å cryoelectron microscopy (cryo-EM) structure of the eight-subunit T3 SAMase-MetK complex. Structure-guided mutagenesis reveals that this interaction stabilizes T3 SAMase in vivo, further stimulating its anti-BREX activity. This work provides insights in the versatility of bacteriophage counterdefense mechanisms and highlights the role of SAM as a co-factor of diverse bacterial immunity systems.


Asunto(s)
Bacteriófago T3 , Bacteriófagos , Bacteriófago T3/metabolismo , Microscopía por Crioelectrón , Escherichia coli/genética , S-Adenosilmetionina/metabolismo , Bacteriófagos/genética
2.
Elife ; 102021 02 10.
Artículo en Inglés | MEDLINE | ID: mdl-33567250

RESUMEN

The first S-adenosyl methionine (SAM) degrading enzyme (SAMase) was discovered in bacteriophage T3, as a counter-defense against the bacterial restriction-modification system, and annotated as a SAM hydrolase forming 5'-methyl-thioadenosine (MTA) and L-homoserine. From environmental phages, we recently discovered three SAMases with barely detectable sequence similarity to T3 SAMase and without homology to proteins of known structure. Here, we present the very first phage SAMase structures, in complex with a substrate analogue and the product MTA. The structure shows a trimer of alpha-beta sandwiches similar to the GlnB-like superfamily, with active sites formed at the trimer interfaces. Quantum-mechanical calculations, thin-layer chromatography, and nuclear magnetic resonance spectroscopy demonstrate that this family of enzymes are not hydrolases but lyases forming MTA and L-homoserine lactone in a unimolecular reaction mechanism. Sequence analysis and in vitro and in vivo mutagenesis support that T3 SAMase belongs to the same structural family and utilizes the same reaction mechanism.


Bacteria can be infected by viruses known as bacteriophages. These viruses inject their genetic material into bacterial cells and use the bacteria's own machinery to build the proteins they need to survive and infect other cells. To protect themselves, bacteria produce a molecule called S-adenosyl methionine, or SAM for short, which deposits marks on the bacteria's DNA. These marks help the bacteria distinguish their own genetic material from the genetic material of foreign invaders: any DNA not bearing the mark from SAM will be immediately broken down by the bacterial cell. This system helps to block many types of bacteriophage infections, but not all. Some bacteriophages carry genes that code for enzymes called SAMases, which can break down SAM, switching off the bacteria's defenses. The most well-known SAMase was first discovered in the 1960s in a bacteriophage called T3. Chemical studies of this SAMase suggested that it works as a 'hydrolase', meaning that it uses water to break SAM apart. New SAMases have since been discovered in bacteriophages from environmental water samples, which, despite being able to degrade SAM, are genetically dissimilar to one another and the SAMase in T3. This brings into question whether these enzymes all use the same mechanism to break SAM down. To gain a better understanding of how these SAMases work, Guo, Söderholm, Kanchugal, Isaksen et al. solved the crystal structure of one of the newly discovered enzymes called Svi3-3. This revealed three copies of the Svi3-3 enzyme join together to form a unit that SAM binds to at the border between two of the enzymes. Computer simulations of this structure suggested that Svi3-3 holds SAM in a position where it cannot interact with water, and that once in the grip of the SAMase, SAM instead reacts with itself and splits into two. Experiments confirmed these predictions for Svi3-3 and the other tested SAMases. Furthermore, the SAMase from bacteriophage T3 was also found to degrade SAM using the same mechanism. This shows that this group of SAMases are not hydrolases as originally thought, but in fact 'lyases': enzymes that break molecules apart without using water. These findings form a starting point for further investigations into how SAM lyases help bacteriophages evade detection. SAM has various different functions in other living organisms, and these lyases could be used to modulate the levels of SAM in future studies investigating its role.


Asunto(s)
Bacteriófago T3/genética , Liasas/genética , Proteínas Virales/genética , Bacteriófago T3/metabolismo , Escherichia coli/virología , Liasas/metabolismo , S-Adenosilmetionina/metabolismo , Proteínas Virales/metabolismo
3.
Biochim Biophys Acta Gene Regul Mech ; 1861(2): 158-166, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29357316

RESUMEN

The selective inhibition of transcription of a chosen gene by an artificial agent has numerous applications. Usually, these agents are designed to bind a specific nucleotide sequence in the promoter or within the transcribed region of the chosen gene. However, since optimal binding sites might not exist within the gene, it is of interest to explore the possibility of transcription inhibition when the agent is designed to bind at other locations. One of these possibilities arises when an additional transcription initiation site (e.g. secondary promoter) is present upstream from the primary promoter of the target gene. In this case, transcription inhibition might be achieved by inducing the formation of an RNA-DNA hybrid (R-loop) upon transcription from the secondary promoter. The R-loop could extend into the region of the primary promoter, to interfere with promoter recognition by RNA polymerase and thereby inhibit transcription. As a sequence-specific R-loop-inducing agent, a peptide nucleic acid (PNA) could be designed to facilitate R-loop formation by sequestering the non-template DNA strand. To investigate this mode for transcription inhibition, we have employed a model system in which a PNA binding site is localized between the T3 and T7 phage RNA polymerase promoters, which respectively assume the roles of primary and secondary promoters. In accord with our model, we have demonstrated that with PNA-bound DNA substrates, transcription from the T7 promoter reduces transcription from the T3 promoter by 30-fold, while in the absence of PNA binding there is no significant effect of T7 transcription upon T3 transcription.


Asunto(s)
ADN/genética , Ácidos Nucleicos de Péptidos/genética , Regiones Promotoras Genéticas/genética , ARN/genética , Transcripción Genética/genética , Bacteriófago T3/genética , Bacteriófago T3/metabolismo , Bacteriófago T7/genética , Bacteriófago T7/metabolismo , Sitios de Unión/genética , ADN/química , ADN/metabolismo , ARN Polimerasas Dirigidas por ADN/genética , ARN Polimerasas Dirigidas por ADN/metabolismo , Regulación Viral de la Expresión Génica , Modelos Genéticos , Conformación de Ácido Nucleico , Ácidos Nucleicos de Péptidos/metabolismo , ARN/química , ARN/metabolismo , Sitio de Iniciación de la Transcripción , Proteínas Virales/genética , Proteínas Virales/metabolismo
4.
Viruses ; 9(5)2017 05 19.
Artículo en Inglés | MEDLINE | ID: mdl-28534826

RESUMEN

Adenosine triphosphate (ATP) cleavage powers packaging of a double-stranded DNA (dsDNA) molecule in a pre-assembled capsid of phages that include T3. Several observations constitute a challenge to the conventional view that the shell of the capsid is energetically inert during packaging. Here, we test this challenge by analyzing the in vitro effects of ATP on the shells of capsids generated by DNA packaging in vivo. These capsids retain incompletely packaged DNA (ipDNA) and are called ipDNA-capsids; the ipDNA-capsids are assumed to be products of premature genome maturation-cleavage. They were isolated via preparative Nycodenz buoyant density centrifugation. For some ipDNA-capsids, Nycodenz impermeability increases hydration and generates density so low that shell hyper-expansion must exist to accommodate associated water. Electron microscopy (EM) confirmed hyper-expansion and low permeability and revealed that 3.0 mM magnesium ATP (physiological concentration) causes contraction of hyper-expanded, lowpermeability ipDNA-capsids to less than mature size; 5.0 mM magnesium ATP (border of supraphysiological concentration) or more disrupts them. Additionally, excess sodium ADP reverses 3.0 mM magnesium ATP-induced contraction and re-generates hyper-expansion. The Nycodenz impermeability implies assembly perfection that suggests selection for function in DNA packaging. These findings support the above challenge and can be explained via the assumption that T3 DNA packaging includes a back-up cycle of ATP-driven capsid contraction and hyper-expansion.


Asunto(s)
Adenosina Trifosfato/farmacología , Bacteriófago T3/genética , Cápside/efectos de los fármacos , Empaquetamiento del ADN , ADN Viral/genética , Adenosina Difosfato/metabolismo , Adenosina Trifosfato/metabolismo , Bacteriófago T3/metabolismo , Bacteriófago T3/ultraestructura , Cápside/metabolismo , Cápside/ultraestructura , Proteínas de la Cápside/genética , ADN Viral/metabolismo , Electroforesis en Gel de Poliacrilamida , Microscopía Electrónica , Permeabilidad/efectos de los fármacos , Ensamble de Virus/efectos de los fármacos
5.
PLoS One ; 10(6): e0130639, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26114300

RESUMEN

The objective of this study was to determine the genomic changes that underlie coevolution between Escherichia coli B and bacteriophage T3 when grown together in a laboratory microcosm. We also sought to evaluate the repeatability of their evolution by studying replicate coevolution experiments inoculated with the same ancestral strains. We performed the coevolution experiments by growing Escherichia coli B and the lytic bacteriophage T3 in seven parallel continuous culture devices (chemostats) for 30 days. In each of the chemostats, we observed three rounds of coevolution. First, bacteria evolved resistance to infection by the ancestral phage. Then, a new phage type evolved that was capable of infecting the resistant bacteria as well as the sensitive bacterial ancestor. Finally, we observed second-order resistant bacteria evolve that were resistant to infection by both phage types. To identify the genetic changes underlying coevolution, we isolated first- and second-order resistant bacteria as well as a host-range mutant phage from each chemostat and sequenced their genomes. We found that first-order resistant bacteria consistently evolved resistance to phage via mutations in the gene, waaG, which codes for a glucosyltransferase required for assembly of the bacterial lipopolysaccharide (LPS). Phage also showed repeatable evolution, with each chemostat producing host-range mutant phage with mutations in the phage tail fiber gene T3p48 which binds to the bacterial LPS during adsorption. Two second-order resistant bacteria evolved via mutations in different genes involved in the phage interaction. Although a wide range of mutations occurred in the bacterial waaG gene, mutations in the phage tail fiber were restricted to a single codon, and several phage showed convergent evolution at the nucleotide level. These results are consistent with previous studies in other systems that have documented repeatable evolution in bacteria at the level of pathways or genes and repeatable evolution in viruses at the nucleotide level. Our data are also consistent with the expectation that adaptation via loss-of-function mutations is less constrained than adaptation via gain-of-function mutations.


Asunto(s)
Bacteriófago T3 , Evolución Molecular Dirigida , Proteínas de Escherichia coli , Escherichia coli , Glucosiltransferasas , Mutación Missense , Proteínas Virales , Sustitución de Aminoácidos , Bacteriófago T3/genética , Bacteriófago T3/metabolismo , Escherichia coli/genética , Escherichia coli/virología , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Glucosiltransferasas/genética , Glucosiltransferasas/metabolismo , Proteínas Virales/genética , Proteínas Virales/metabolismo
6.
Environ Sci Technol ; 43(15): 5940-6, 2009 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-19731701

RESUMEN

Airborne virus capture and inactivation were studied in an electrostatic precipitator (ESP) at applied voltages from -10 to +10 kV using aerosolized bacteriophages T3 and MS2. For each charging scenario, samples were collected from the effluent air stream and assayed for viable phages using plaque assays and for nucleic acids using quantitative polymerase chain reaction (qPCR) assays. At higher applied voltages, more virus particles were captured from air with maximum log reductions of 6.8 and 6.3 for the plaque assay and 4.2 and 3.5 for the qPCR assay at -10 kV for T3 and MS2, respectively. Beyond corona inception (i.e., at applied voltages of -10, -8, +8, and +10 kV), log reduction values obtained with the plaque assay were much higher compared to those of the qPCR assay because nonviable particles, while present in the effluent were unaccounted for in the plaque assay. Comparisons of these assays showed that in-flight inactivation (i.e., inactivation without capture) was greater for the highest applied voltages with a log inactivation of 2.6 for both phages at -10 kV. We have demonstrated great potential for virus capture and inactivation via continual ion and reactive species bombardment when conditions in the ESP are enforced to generate a corona discharge.


Asunto(s)
Bacteriófago T3/metabolismo , Monitoreo del Ambiente/métodos , Levivirus/metabolismo , Aerosoles , Microbiología del Aire , Diseño de Equipo , Ácidos Nucleicos/química , Reacción en Cadena de la Polimerasa , Electricidad Estática , Ensayo de Placa Viral , Virión , Virus , Rayos X
7.
Virol J ; 4: 30, 2007 Mar 13.
Artículo en Inglés | MEDLINE | ID: mdl-17355641

RESUMEN

BACKGROUND: The genomes of both long-genome (> 200 Kb) bacteriophages and long-genome eukaryotic viruses have cellular gene homologs whose selective advantage is not explained. These homologs add genomic and possibly biochemical complexity. Understanding their significance requires a definition of complexity that is more biochemically oriented than past empirically based definitions. HYPOTHESIS: Initially, I propose two biochemistry-oriented definitions of complexity: either decreased randomness or increased encoded information that does not serve immediate needs. Then, I make the assumption that these two definitions are equivalent. This assumption and recent data lead to the following four-part hypothesis that explains the presence of cellular gene homologs in long bacteriophage genomes and also provides a pathway for complexity increases in prokaryotic cells: (1) Prokaryotes underwent evolutionary increases in biochemical complexity after the eukaryote/prokaryote splits. (2) Some of the complexity increases occurred via multi-step, weak selection that was both protected from strong selection and accelerated by embedding evolving cellular genes in the genomes of bacteriophages and, presumably, also archaeal viruses (first tier selection). (3) The mechanisms for retaining cellular genes in viral genomes evolved under additional, longer-term selection that was stronger (second tier selection). (4) The second tier selection was based on increased access by prokaryotic cells to improved biochemical systems. This access was achieved when DNA transfer moved to prokaryotic cells both the more evolved genes and their more competitive and complex biochemical systems. TESTING THE HYPOTHESIS: I propose testing this hypothesis by controlled evolution in microbial communities to (1) determine the effects of deleting individual cellular gene homologs on the growth and evolution of long genome bacteriophages and hosts, (2) find the environmental conditions that select for the presence of cellular gene homologs, (3) determine which, if any, bacteriophage genes were selected for maintaining the homologs and (4) determine the dynamics of homolog evolution. IMPLICATIONS OF THE HYPOTHESIS: This hypothesis is an explanation of evolutionary leaps in general. If accurate, it will assist both understanding and influencing the evolution of microbes and their communities. Analysis of evolutionary complexity increase for at least prokaryotes should include analysis of genomes of long-genome bacteriophages.


Asunto(s)
Bacteriófago T3/genética , Bacteriófago T7/genética , Evolución Molecular , Células Procariotas/virología , Selección Genética , Proteínas Virales/genética , Animales , Bacteriófago T3/metabolismo , Bacteriófago T7/metabolismo , Duplicación de Gen , Transferencia de Gen Horizontal , Genoma Viral , Modelos Genéticos , Proteínas Virales/metabolismo
8.
Biophys J ; 69(6): 2256-67, 1995 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8599633

RESUMEN

Many molecular motors move unidirectionally along a DNA strand powered by nucleotide hydrolysis. These motors are multimeric ATPases with more than one hydrolysis site. We present here a model for how these motors generate the requisite force to process along their DNA track. This novel mechanism for force generation is based on a fluctuating electrostatic field driven by nucleotide hydrolysis. We apply the principle to explain the motion of certain DNA helicases and the portal protein, the motor that bacteriophages use to pump the genome into their capsids. The motor can reverse its direction without reversing the polarity of its electrostatic field, that is, without major structural modifications of the protein. We also show that the motor can be driven by an ion gradient; thus the mechanism may apply as well to the bacterial flagellar motor and to ATP synthase.


Asunto(s)
Adenosina Trifosfatasas/química , ADN de Cadena Simple/química , ADN de Cadena Simple/metabolismo , ADN/química , ADN/metabolismo , Modelos Teóricos , Conformación de Ácido Nucleico , Adenosina Trifosfatasas/metabolismo , Bacteriófago T3/metabolismo , Bacteriófago T7/enzimología , ADN Helicasas/química , ADN Helicasas/metabolismo , Cinética , Matemática , Modelos Estructurales , Conformación Proteica , Proteínas Virales/química , Proteínas Virales/metabolismo
9.
Virology ; 211(2): 516-24, 1995 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-7645255

RESUMEN

A large subunit of bacteriophage T3 packaging enzyme, a product of gene 19 (gp19, 586 amino acid residues), binds a prohead prior to DNA translocation in DNA packaging. Its C-terminal region (571 to 576, Region I) is of crucial importance for prohead binding. To elucidate the functional role(s) of Region I in DNA packaging, a hexapeptide (6pT3) corresponding to the Region I sequence and its variants were synthesized and their effects on DNA packaging in a defined in vitro system were examined. 6pT3 did not inhibit gp19wt (wild type)-prohead binding but interfered with their functional interaction, resulting in inhibition of DNA packaging. The inhibitory effect of 6pT3 on gp19wt was reversible. The effect of 6pT3 was examined with gp19 delta C10, which was active in DNA packaging in spite of lacking the extreme C-terminal 10 amino acids (Region II). The inhibitory effect on gp19 delta C10 was more severe than that on gp19wt and was irreversible. From these results, we concluded that the prohead binding domain is composed of two subdomains: Region I is a "core" domain, and its binding to the prohead is crucial for DNA packaging, and Region II is an "anchor" domain stabilizing the binding by Region I.


Asunto(s)
Bacteriófago T3/metabolismo , Endodesoxirribonucleasas/metabolismo , Oligopéptidos/metabolismo , Proteínas Virales/metabolismo , Secuencia de Aminoácidos , ADN Viral/metabolismo , Datos de Secuencia Molecular , Unión Proteica
10.
J Mol Biol ; 235(1): 248-59, 1994 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-8289246

RESUMEN

Intracellular phage T3 DNA is synthesized as a concatemer in which unit-length molecules are jointed together in head-to-tail fashion through terminally redundant sequences. The concatemeric DNA is processed and packaged into the prohead with the aid of non-capsid proteins, gp18 and gp19. We have developed a defined system, composed of purified gp18, gp19 and proheads, and a crude system, composed of lysates of T3 infected cells, for in vitro packaging of T3 DNA. The defined system displays an ATPase activity which is composed of DNA packaging-dependent and -independent ATPases (pac- and nonpac-ATPases, respectively). In the crude system, DNA is packaged by a way of concatemer as an intermediate. gp19 has ATP binding activity and three ATP binding and two Mg2+ binding consensus motifs in its amino acid sequence. We have expanded the previous studies on the roles of these domains in the DNA packaging reaction by more extensive analysis by site-directed mutagenesis. gp19 mutants, including the previously isolated four mutants, were divided into four groups according to the DNA packaging activity in the defined and crude systems: group 1 mutants were defective in both systems (gp19-G61D, which is a gp19 mutant with Gly to Asp at amino acid 61 and so on, and gp19-H344D); the group 2 mutant had decreased activity in both systems (gp19-G429R); group 3 mutants were active in the defined system but defective in the crude system (gp19-G63D, gp19-H347R, gp19-G367D, gp19-G369D, gp19-G424E); group 4 mutants had almost the same activity as gp19-wt (gp19-K64T, gp19-K370I, gp19-G429L, gp19-K430T and gp19-H553L). Group 1 mutants had an altered conformation, resulting in defective interaction with ATP and in abortive binding to the prohead, and lost specifically the pac-ATPase activity. The group 2 mutant had an increased pac-ATPase activity in spite of the decreased DNA packaging activity, indicating that this mutant is inefficient in coupling of ATP hydrolysis to DNA translocation. The inability of the group 3 mutants except gp19-H347R to package DNA in the crude system would be due to a defect in processing of concatemer DNA. gp19-H347R would be a mutant defective in the initiation event(s) of DNA packaging.


Asunto(s)
Adenosina Trifosfatasas/metabolismo , Bacteriófago T3/metabolismo , Proteínas Virales/metabolismo , Secuencia de Aminoácidos , Bacteriófago T3/genética , Secuencia de Bases , Sitios de Unión , ADN Viral/biosíntesis , Desoxirribonucleasas/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Oligodesoxirribonucleótidos , Proteínas Virales/química
11.
DNA Res ; 1(6): 289-96, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7719924

RESUMEN

To sequence a DNA segment inserted into a cosmid vector under the directed sequencing strategy, we established a simple and rapid method for generating nested deletions which uses the in vitro packaging system of bacteriophage T3 DNA. The principle is based on the previous finding that this system can translocate any linear double-stranded DNA up to 40 kb into the phage capsid in a time-dependent manner and the encapsulated DNA becomes DNase-resistant. For this purpose, we constructed a cosmid vector that carries two different antibiotic selection markers at both sides of the multiple cloning site, and after insertion of a DNA segment, the clone was linearized by lambda-terminase at the cos site. After the packaging reaction in vitro followed by DNase treatment, the encapsulated DNA was introduced into Escherichia coli cells to give clones with unidirectional deletions by differential antibiotic selection. Restriction and sequence analyses of deletion clones demonstrated that an ordered set of clones with nested deletions, ranging from less than 1 kb to 25 kb, was created from either the end of the DNA segment. Thus, nested deletion clones that cover the entire region of a approximately 40-kb cosmid insert can be obtained by a single packaging reaction, and its restriction map can be simultaneously obtained.


Asunto(s)
Bacteriófago T3/metabolismo , Cápside/metabolismo , Cósmidos/genética , ADN Recombinante/análisis , ADN Viral/metabolismo , Vectores Genéticos/genética , Análisis de Secuencia de ADN/métodos , Eliminación de Secuencia , ADN Recombinante/genética , ADN Recombinante/metabolismo , ADN Viral/genética , Desoxirribonucleasa I/metabolismo , Farmacorresistencia Microbiana/genética , Escherichia coli/genética , Selección Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...